AI Platform Inspired by Eating Disorder Survivor to Transform UK Care
A Jersey woman whose life was once threatened by a severe eating disorder is now at the heart of a technological breakthrough aimed at transforming eating disorder care across the United Kingdom.
Amy Dingle, currently Deputy Chief Executive of Jersey Eating Disorders Support (JEDS), has lent her name and personal story to ‘AMY’ – a first-of-its-kind artificial intelligence system designed to help clinicians identify early warning signs of eating disorders and improve patient outcomes.
Dingle’s own struggle with anorexia began around the age of 12, intensifying during her university years and requiring multiple hospital admissions. Her experience and subsequent treatment by Bramacare in 2017, directly informed the development of the new technology. AMY integrates a patient’s complete clinical data into a single, continuously updated digital record.
The launch of AMY comes as eating disorder cases continue to rise, particularly among young people, and National Health Service (NHS) services face increasing pressure from growing referral numbers. As of June 2025, Jersey’s government-supported eating disorder pathway was assisting 22 individuals under 18 and 29 adults.
Dingle emphasized the importance of coordinated care during her own treatment. “For anyone going through what I went through, it’s incredibly important that the people caring for you have the right information at the right time and are fully co-ordinated in their approach,” she said. “AMY will give clinical teams the tools and insight they need to deliver the highest standard of care, providing patients with what I was fortunate to receive – a real chance at recovery.”
Alongside Dingle, her mother Karen Dingle, who similarly runs JEDS as Chief Executive, has been instrumental in the charity’s work. Karen Dingle has supported her daughter’s struggles and co-leads the charity alongside Amy.
Developed by specialist eating disorder service Bramacare, based in Ipswich, AMY continuously monitors vital indicators such as heart readings, blood results, weight fluctuations, medication adherence, and dietary intake – all in real time. Unlike conventional systems, AMY proactively detects patterns indicative of deteriorating conditions and alerts clinicians before a patient reaches a critical state.
Bramacare Chief Executive Laetitia Beaujard-Ramoo explained the rationale behind naming the platform after Dingle. “Naming this platform AMY was the easiest decision we ever made. Amy was our first patient, and her experience showed us what good care should look like: co-ordinated, consistent, and centred around the individual. AMY brings all patient information together in one place to give better oversight on patients and reduce admin time to provide better care outcomes.”
The platform, developed by a specialist clinical team, is currently undergoing formal evaluation in preparation for regulatory approval. Pilot programs with NHS partners are anticipated to commence later this year.